Explore the full record of transactions filed by Rogers, Adam. Director active across 1 company, notably NervGen Pharma Corp.. In total, 5 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €3.1m. Activity tracked since 13 May 2026. The latest transaction was filed on 30 June 2026 (46 - Compensation for services). Regulator: SEDI. All data is free.
Companies and markets linked to Rogers, Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.